Log In
Print
BCIQ
Print
Print this Print this
 

nitazoxanide (NT-300)

  Manage Alerts
Collapse Summary General Information
Company Romark Laboratories L.C.
DescriptionOral controlled-release tablet with nitazoxanide
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationInfluenza virus
Indication DetailsTreat acute uncomplicated influenza infection; Treat influenza-like illness in children
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today